Biological Effects of Individually Synthesized TNF-Binding Domain of Variola Virus CrmB Protein Authors
First Online: 22 June 2014 Received: 20 February 2013 DOI:
Cite this article as: Tsyrendorzhiev, D.D., Orlovskaya, I.A., Sennikov, S.V. et al. Bull Exp Biol Med (2014) 157: 249. doi:10.1007/s10517-014-2537-6
The biological characteristics of a 17-kDa protein synthesized in bacterial cells, a TNF-binding domain (VARV-TNF-BP) of a 47-kDa variola virus CrmB protein (VARV-CrmB) consisting of TNF-binding and chemokine-binding domains, were studied. Removal of the C-terminal chemokine-binding domain from VARV-CrmB protein was inessential for the effi ciency of its inhibition of TNF cytotoxicity towards L929 mouse fi broblast culture and for TNF-induced oxidative metabolic activity of mouse blood leukocytes. The results of this study could form the basis for further studies of VARV-TNF-BP mechanisms of activity for prospective use in practical medicine.
Keywords variola virus leukocytes tumor necrosis factor-binding protein cytotoxicity oxidative metabolic function References
I. P. Gileva, E. M. Malkova, E. S. Nepomnyashchikh,
et al., Tsitokin. Vospal., 5, No. 1, 44-49 (2006).
I. P. Gileva, T. S. Nepomnyashchikh, I. A. Ryazankin, and S. N. Shchelkunov,
Biokhimiya, 74, No. 12, 1664-1671 (2009).
I.P. Gileva, I. A. Ryazankin, T. S. Nepomnyashchikh,
, No. 2, 245-254 (2005).
L. R. Lebedev, I. A. Ryazankin, A. A. Sizov,
et al., Biotekhnol., No. 6, 14-18 (2001).
T. S. Nepomnyashchikh, D. V. Antonets, I. P. Gileva, and S. N. Shchelkunov,
Uspekhi Sovrem. Biol., 127, No. 6, 558-569 (2007).
T. V. Tregubchak, T. S. Nepomnyashchikh, D. V. Antonets, and S. N. Shchelkunov,
Patent RF No. 2471869. Recombinant DNA Plasmids pQE-60-TNFR-CrmB-Ind-67 and pFastBac1- G2R-dSECRET, containing Variola Virus Genome Fragment Coding for Tumor Necrosis Factor, Binding CrmB Protein Domain and Bv/G2R-dSECRET Baculovirus Strain, Producing Secretory TNF-Binding Protein of Variola Virus CrmB with Deleted Secret Domain, Bull. No. 1 (January 10, 2013).
D. D. Tsyrendorzhiev, S. V. Sennikov, E. A. Vyazovaya,
et al., Byull. Sib. Otdel. Ross. Akad. Med. Nauk, 31, No. 3, 73-79 (2011).
D. D. Tsyrendorzhiev, S. V. Sennikov, I. A. Orlovskaya,
et al., Immunol., 32, No. 4, 209-213 (2011).
A. Alejo, M. B. Ruiz-Arguello, Y. Ho,
Proc. Natl. Acad. Sci. USA
, No. 15, 5995-6000 (2006).
PubMedCentral PubMed CrossRef
J. M. Bathon, R. W. Martin, R. M. Fleischmann,
N. Engl. J. Med.
, No. 22, 1586-1593 (2000).
M. M. Bradford,
, 248-254 (1976).
I. P. Gileva, T. S. Nepomnyashchikh, D. V. Antonets,
Biochim. Biophys. Acta
, No. 11, 1710-1718 (2006).
S. A. Siegel, D. J. Shealy, M. T. Nakada,
, No. 1, 15-25 (1995).
T. Tono-oka, N. Ueno, T. Matsumoto,
Clin. Immunol. Immunopathol.
, No. 1, 66-75 (1983).
M. E. Weinblatt, E. C. Keystone, D. E. Furst,
, No. 1, 35-45 (2003).
PubMed CrossRef Copyright information
© Springer Science+Business Media New York 2014